Inspire ANTI SNORING Implant Review
The Inspire ANTI SNORING Implant is a medical device that’s implanted into the body for the treating snoring and obstructive anti snoring (OSA) syndrome.
Obstructive Sleep Apnea Syndrome
Obstructive sleep apnea syndrome is really a disease due to relapsing episodes of sleep apnea. This is usually a condition where breathing stops for a lot more than 10 seconds, during which oxygen saturation in the blood is reduced by more than 4%.
OSA syndrome occurs during sleep, once the muscles of upper airways relax, causing the obstruction of the respiratory tract. This results in deterioration of blood oxygenation and provokes short unconscious wake-up episodes throughout the night. An unhealthy pattern of sleep places pressure on the body, causing increased blood circulation pressure and development of severe diseases. The diseases due to OSA can be physical, such as hypertension, myocardium infarction and stroke. They could also be mental, including depression, chronic fatigue syndrome, lack of memory and concentration.
Before any treatment, a sleep study or a polysomnography is needed. The polysomnography calculates the apnea index, which is the frequency of apnea episodes during one hour of sleep and determines the severity of the condition. ufa The apnea index is considered significant if there are a lot more than 20 apnea episodes each hour, whatever the presence or lack of clinical symptoms.
The gold standard of treatment for OSA syndrome is CPAP-therapy. However, CPAP therapy is not for everyone as many folks think it is uncomfortable to sleep with the mask on the face and the machine itself could be loud, especially as it commonly sits near the head. Only 25% of patients can use CPAP-therapy for an extended period of time.
Therefore, recently Inspire Medical Systems Inc. has come up with a very effective solution with the Inspire Sleep Apnea Implant.
How The Inspire ANTI SNORING Implant Works
The Inspire ANTI SNORING Implant is a battery operated device that promotes electrostimulation of the sublingual nerve. The battery life is approximately 10 years.
The main unit of the device is placed beneath the skin, on the front right side of the chest and it monitors the phase of breathing. Another electrode is implanted for stimulation of the sublingual nerve, which creates muscle tension. This opens top of the airways and allows the tongue to stick out, and helps maintain the airways open during sleep.
In addition to the two electrodes, this device also contains a handy small remote switch, that actually turns on these devices before sleep and switches it off once awake. This disables the electrodes from disturbing the processes of communication and eating through the active phase of your day, when a person needs physiological narrowing of the larynx and tongue movements for these procedures.
The patient may feel light involuntary contractions of the larynx, or tongue movements during initial use of these devices. These movements do not cause pain, instead just a minor discomfort. These unpleasant effects disappear after the first few uses of these devices.
Generally, the implant should be checked one or two 2 times each year. However, based on the situation, an Inspire therapy-trained doctor may consult patients more or less often.
The Inspire ANTI SNORING Implant is only suitable for:
Patients who are more than 22 years old.
Patients who’ve been diagnosed with moderate or severe obstructive sleep apnea syndrome.
Patients having an apnea index in the range of 20 to 65.
Patients who are not comfortable with using CPAP therapy or didn’t work.
Patients with a body mass index of less than 32.
Body mass index (BMI) = weight (kg) / height^2 (m2).
An individual with a weight of 80 kg and a height of 170 cm has
BMI = 80kg / (1.7m ^ 2) = 80 / 2.89 = 27.68 kg/ m2
The Inspire ANTI SNORING Implant may potentially replace CPAP therapy as ‘the gold standard’ of treatment for obstructive sleep apnea syndrome. A study by Dr. Ryan J. et al. has shown that after implantation of the Inspire Sleep Apnea Implant, snoring is greatly decreased. A percentage of “no” or “soft” snoring changed from 22% at beginning of the treatment to 88% at 12 months and 91% at 24 months following the treatment. Also, the apnea index was reduced from 31 to 14. 82% of the patients in the study reported a nightly use of this therapy for five years. Therefore, it is evident that this method is highly effective and easy to use!